Cosmos Health Inc当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在药品行业排名124/158位。机构持股占比非常高,近一月多位分析师给出公司评级为。最高目标价3.00。中期看,股价处于下降通道。近一个月,市场表现非常差,但基本面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
Cosmos Health Inc评分
相关信息
行业排名
124 / 158
全市场排名
404 / 4582
所属行业
药品
压力支撑
由于公司未披露,未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
0
位分析师
--
评级
3.000
目标均价
+511.87%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议
Cosmos Health Inc亮点
亮点风险
Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
公司代码COSM
公司Cosmos Health Inc
CEOSiokas (Grigorios)
网址https://www.cosmosholdingsinc.com/
常见问题
Cosmos Health Inc(COSM)的当前股价是多少?
Cosmos Health Inc(COSM)的当前股价是 0.487。
Cosmos Health Inc的股票代码是什么?
Cosmos Health Inc的股票代码是COSM。
Cosmos Health Inc股票的52周最高点是多少?
Cosmos Health Inc股票的52周最高点是1.320。
Cosmos Health Inc股票的52周最低点是多少?
Cosmos Health Inc股票的52周最低点是0.280。
Cosmos Health Inc的市值是多少?
Cosmos Health Inc的市值是15.52M。
Cosmos Health Inc的净利润是多少?
Cosmos Health Inc的净利润为-22.38M。
现在Cosmos Health Inc(COSM)的股票是买入、持有还是卖出?
根据分析师评级,Cosmos Health Inc(COSM)的总体评级为--,目标价格为3.000。